Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement

Sanofi’s big-selling blood thinner Lovenox has long faced generic competition in the U.S., but now rival generics makers are squashing long-running lawsuits over their own versions of the drug.